Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
JAMA Network Open
|
August 5, 2025
Unsolicited Patient Complaints and Industry Payments for US Physicians
Yong Hyun Park, Henry John Domenico, Zhuo Tony Su, et al.
Journal of General Internal Medicine
|
February 22, 2024
Correction to: The Association of Subspecialty and Sex with Industry Payments to Internal Medicine Physicians Who Recently Completed Training
Yong Hyun Park, Paul O'Rourke, Andrew Gabrielson, et al.
Journal of General Internal Medicine
|
August 7, 2023
The Association of Subspecialty and Sex with Industry Payments to Internal Medicine Physicians Who Recently Completed Training
Yong Hyun Park, Paul O'Rourke, Andrew Gabrielson, et al.
The Journal of Urology
|
June 24, 2026
The Effect of Prostate Volume and 5-Alpha Reductase Inhibitor Use on Grade Progression and Treatment Decisions in Patients with Prostate Cancer on Active Surveillance
Jack A Campbell, David Ali, Michael E Rezaee, et al.
European Urology Oncology
|
August 24, 2021
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature
Adam K Aragaki, Yuezhou Jing, Jean Hoffman-Censits, et al.
BJU International
|
May 14, 2025
Prostate cancer active surveillance in solid organ transplant: a matched study and literature review
Mark N Alshak, Michelle I Higgins, Aurora J Grutman, et al.
Human Molecular Genetics
|
May 28, 2004
Expression profiling of the developing and mature Nrl-/- mouse retina: identification of retinal disease candidates and transcriptional regulatory targets of Nrl
Shigeo Yoshida, Alan J Mears, James S Friedman, et al.
Urologic Oncology
|
September 18, 2023
Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification
Claire M de la Calle, Yuezhou Jing, Mufaddal M Mamawala, et al.
Cancer Research Communications
|
August 19, 2025
Novel pre-treatment autoantibodies correlate with enfortumab vedotin-related dermatologic events in patients with advanced urothelial cancer
Evangelia Vlachou, Burles A Johnson Iii, David J McConkey, et al.
The Journal of Urology
|
February 9, 2026
Results from the ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) Randomized Controlled Trial
Michael E Rezaee, Michelle I Higgins, Zhuo Tony Su, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
JAMA Network Open
|
August 5, 2025
Unsolicited Patient Complaints and Industry Payments for US Physicians
Yong Hyun Park, Henry John Domenico, Zhuo Tony Su, et al.
Journal of General Internal Medicine
|
February 22, 2024
Correction to: The Association of Subspecialty and Sex with Industry Payments to Internal Medicine Physicians Who Recently Completed Training
Yong Hyun Park, Paul O'Rourke, Andrew Gabrielson, et al.
Journal of General Internal Medicine
|
August 7, 2023
The Association of Subspecialty and Sex with Industry Payments to Internal Medicine Physicians Who Recently Completed Training
Yong Hyun Park, Paul O'Rourke, Andrew Gabrielson, et al.
The Journal of Urology
|
June 24, 2026
The Effect of Prostate Volume and 5-Alpha Reductase Inhibitor Use on Grade Progression and Treatment Decisions in Patients with Prostate Cancer on Active Surveillance
Jack A Campbell, David Ali, Michael E Rezaee, et al.
European Urology Oncology
|
August 24, 2021
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature
Adam K Aragaki, Yuezhou Jing, Jean Hoffman-Censits, et al.
BJU International
|
May 14, 2025
Prostate cancer active surveillance in solid organ transplant: a matched study and literature review
Mark N Alshak, Michelle I Higgins, Aurora J Grutman, et al.
Human Molecular Genetics
|
May 28, 2004
Expression profiling of the developing and mature Nrl-/- mouse retina: identification of retinal disease candidates and transcriptional regulatory targets of Nrl
Shigeo Yoshida, Alan J Mears, James S Friedman, et al.
Urologic Oncology
|
September 18, 2023
Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification
Claire M de la Calle, Yuezhou Jing, Mufaddal M Mamawala, et al.
Cancer Research Communications
|
August 19, 2025
Novel pre-treatment autoantibodies correlate with enfortumab vedotin-related dermatologic events in patients with advanced urothelial cancer
Evangelia Vlachou, Burles A Johnson Iii, David J McConkey, et al.
The Journal of Urology
|
February 9, 2026
Results from the ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) Randomized Controlled Trial
Michael E Rezaee, Michelle I Higgins, Zhuo Tony Su, et al.
Page
of 7